###begin article-title 0
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 355 361 <span type="species:ncbi:9606">humans</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 868 872 <span type="species:ncbi:10090">mice</span>
The dopamine transporter (DAT) plays a critical role in regulating dopamine neurotransmission. Variations in DAT or changes in basal dopaminergic tone have been shown to alter behavior and drug responses. DAT is one of the three known high affinity targets for cocaine, a powerful psychostimulant that produces reward and stimulates locomotor activity in humans and animals. We have shown that cocaine no longer produces reward in knock-in mice with a cocaine insensitive mutant DAT (DAT-CI), suggesting that cocaine inhibition of DAT is critical for its rewarding effect. However, in DAT-CI mice, the mutant DAT has significantly reduced uptake activity resulting in elevated basal dopaminergic tone, which might cause adaptive changes that alter responses to cocaine. Therefore, the objective of this study is to determine how elevated dopaminergic tone affects how mice respond to cocaine.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
We examined the cocaine induced behavior of DAT knockdown mice that have DAT expression reduced by 90% when compared to the wild type mice. Despite a dramatic reduction of DAT expression and marked elevation in basal dopamine tone, cocaine produced reward, as measured by conditioned place preference, and stimulated locomotor activity in these mice.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 220 224 <span type="species:ncbi:10090">mice</span>
A reduction in DAT expression and elevation of dopaminergic tone do not lead to adaptive changes that abolish the rewarding and stimulating effects of cocaine. Therefore, the lack of reward to cocaine observed in DAT-CI mice is unlikely to have resulted from the reduced DAT activity but instead is likely due to the inability of cocaine to block the mutated DAT and increase extracellular dopamine. This study supports the conclusion that the blockade of DAT is required for cocaine reward and locomotor stimulation.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 935 936 935 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1076 1077 1076 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1078 1079 1078 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
Cocaine is a powerful psychostimulant and an addictive drug of abuse. Considerable evidence indicates that the blockade of the dopamine transporter (DAT) by cocaine and the subsequent elevation of extracellular dopamine (DA) primarily mediate the stimulating and rewarding effects of cocaine [1-4]. DA is an important neurotransmitter involved in many critical functions including motor control, emotion, motivation, memory, and reward [5]. The DA transporter is responsible for DA reuptake and recycling, and thus plays a critical role in maintaining DA homeostasis and in regulating DA neurotransmission. Variations or polymorphisms in the DAT gene have been associated with behavioral changes and modified drug response. For instance, it has been shown that the 9-repeat allele of a 3' variable number tandem repeat polymorphism in the DAT gene is associated with lower basal DA tone and greater DA release in response to nicotine [6]. More significantly, the 9-repeat allele has also been associated with attention deficit/hyperactivity disorder and increased aggression [7,8].
###end p 9
###begin p 10
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
###xml 829 833 <span type="species:ncbi:10090">mice</span>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
There is also evidence that changes to DAT in animals can affect their drug responses and behavior. It is widely believed that the addictive psychostimulants elevate locomotor activity and produce reward by activating the dopaminergic system. However, cocaine still produces reward in dopamine transporter knockout mice (DAT-KO mice) [9-11]. Importantly, DAT-KO mice show additional differences from wild type mice. The selective serotonin transporter (SERT) inhibitor fluoxetine and the selective norepinephrine transporter (NET) inhibitor nisoxetine do not produce reward in wild type mice, but both drugs produce reward in DAT-KO mice [12-14]. Fluoxetine and reboxetine (another NET selective inhibitor) have also been reported to increase extracellular DA levels in the nucleus accumbens in DAT-KO mice, but not in wild type mice [13,15,16]. It is likely that the absence of DAT in DAT-KO mice has altered neuronal signaling pathways. Therefore, it is not clear how the modulation of DAT would affect cocaine induced reward and locomotor activity.
###end p 10
###begin p 11
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
To avoid the adaptive changes seen in DAT-KO mice, we previously generated a knock-in mouse line with a cocaine-insensitive DAT (DAT-CI) [17]. In DAT-CI mice, cocaine decreases locomotor activity and does not produce reward as measured by conditioned place preference (CPP) [17]. Our results suggest that the blockade of DAT is required for cocaine induced reward and locomotor stimulation. In DAT-CI mice however, the modified DAT has reduced transport function resulting in elevated extracellular DA levels and hyperactivity. Therefore, it is a concern that cocaine's inability to produce reward or to increase locomotor activity might be due to increased DA basal tone or other adaptations caused by the reduced DA transport function in DAT-CI mice.
###end p 11
###begin p 12
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
A DAT knock-down mouse line (DAT-KD) has been generated which has a 90% reduction in DAT expression compared to the wild type mice [18]. DAT-KD mice display significantly altered behaviors, such as hyperactivity and slower habituation to a novel environment. Importantly, amphetamine, which increases locomotion in wild type mice, reduces locomotor activity in DAT-KD mice [18]. DAT-KD mice also exhibit differences from wild type mice in their response to sweet rewards [19,20]. These studies indicate that alterations in DAT expression can change an animal's behavior and modify its response to drugs including psychostimulants. DAT-KD mice provide a good animal model to test how reduced DAT expression affects cocaine-induced animal behaviors.
###end p 12
###begin p 13
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
In the current study, we compared the cocaine response in DAT-KD mice and wild type mice with two behavioral tests: drug induced locomotion and CPP. Our results revealed the effects of reduced DAT expression on cocaine-elicited animal behaviors.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
Locomotion stimulation
###end title 15
###begin p 16
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 837 842 837 842 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3,66 </sub>
###xml 909 914 909 914 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,66 </sub>
###xml 1005 1010 1005 1010 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3,66 </sub>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 277 282 <span type="species:ncbi:10090">mouse</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 1125 1129 <span type="species:ncbi:10090">mice</span>
###xml 1176 1180 <span type="species:ncbi:10090">mice</span>
###xml 1291 1295 <span type="species:ncbi:10090">mice</span>
###xml 1404 1408 <span type="species:ncbi:10090">mice</span>
###xml 1536 1540 <span type="species:ncbi:10090">mice</span>
###xml 1712 1716 <span type="species:ncbi:10090">mice</span>
###xml 1772 1776 <span type="species:ncbi:10090">mice</span>
First, we examined the effects of cocaine or saline injection on mouse locomotor activity. WT and DAT-KD mice were placed in an open field box (25 cm x 25 cm) and locomotor activity was recorded for 60 minutes. After the habituation period, cocaine or saline were injected and mouse locomotor activities were monitored for another 60 minutes. Figure 1A and 1B show the time course of the response of DAT-KD and wild type mice, respectively, to saline, 5 mg/kg, 10 mg/kg and 20 mg/kg cocaine. DAT-KD mice displayed higher basal locomotor activity (p < 0.001, t-test) than their wild type littermates (Fig. 1C). This observation is consistent with previously published results [18]. Fig. 1D shows the total distance traveled in 30 min after injection of saline or different doses of cocaine. Two way ANOVA detected a main effect of drug (F3,66 = 22.38, p < 0.001) and significant difference between genotypes (F1,66 = 19.57, p < 0.001); but the drug-genotype interaction did not reach a significant level (F3,66 = 2.686, p = 0.053). The data were further analyzed with post hoc Bonferroni tests. Comparing the two genotypes of mice, we found no difference between WT and DAT-KD mice in distance traveled after saline injection (p > 0.05), despite the higher basal locomotor activity in DAT-KD mice. However, 5 mg/kg and 10 mg/kg cocaine had a greater stimulating effect on locomotor activity in the DAT-KD mice (p < 0.01 and p < 0.001), while there was no significant difference in the effects of 20 mg/kg cocaine on the two genotypes of mice (p > 0.05). For the cocaine effect, post hoc tests indicated that 5, 10, and 20 mg/kg cocaine significantly stimulated locomotor activity compared to saline in the DAT-KD mice (p < 0.01, p < 0.001, and p < 0.001). In the wild type mice, 5 mg/kg cocaine did not significantly stimulate locomotor activity, while 10 and 20 mg/kg cocaine did (p > 0.05, p < 0.001, and p < 0.001 respectively).
###end p 16
###begin p 17
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of cocaine on locomotor activity in DAT-KD mutant mice compared to WT mice</bold>
###xml 968 973 968 973 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3,66 </sub>
###xml 1067 1072 1067 1072 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,66 </sub>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 83 87 <span type="species:ncbi:10090">Mice</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
###xml 1026 1030 <span type="species:ncbi:10090">mice</span>
###xml 1046 1050 <span type="species:ncbi:10090">mice</span>
###xml 1346 1350 <span type="species:ncbi:10090">mice</span>
###xml 1369 1373 <span type="species:ncbi:10090">mice</span>
Effect of cocaine on locomotor activity in DAT-KD mutant mice compared to WT mice. Mice were habituated to the locomotor test chamber for 60 minutes. Cocaine or saline were injected (ip) and mice were returned to the test chamber and monitored for another 60 min. A) and B): Time course of locomotor activity of WT mice and DAT-KD mice. Saline, 5 mg/kg, 10 mg/kg or 20 mg/kg cocaine was given at the time indicated by the arrows. Data shown are average distance traveled in 5 min. C) Total distance traveled in 60 minutes for wild type and DAT-KD mice during their habituation to the chambers before drug or saline injection. DAT-KD mice are significantly more active than wild type ice (***, p < 0.001, t-test). D) Total distance traveled in 30 min after the injection of saline or 5, 10, or 20 mg/kg cocaine with 6 - 8 mice in each group. Two-way ANOVA was performed. Cocaine significantly increased locomotor activities in both genotypes of mice (for drug effect, F3,66 = 22.38, p < 0.001) and had greater effect on DAT-KD mice than on the WT mice (for genotype, F1,66 = 19.57, p < 0.001). Error bars represent standard error of means. Post hoc Bonferroni tests versus saline: *, p < 0.05; **, p < 0.01; ***, p < 0.001. Comparing between the two genotypes, 5 mg/kg and 10 mg/kg cocaine had a greater effect on locomotor activity in the DAT-KD mice than in wild type mice (#, p < 0.01).
###end p 17
###begin title 18
Conditioned place preference
###end title 18
###begin p 19
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 304 309 304 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,40 </sub>
###xml 376 381 376 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,40 </sub>
###xml 447 452 447 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,40 </sub>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 886 890 <span type="species:ncbi:10090">mice</span>
Next, we tested whether cocaine can still produce reward in DAT-KD mice using the CPP test. As shown in Fig. 2, 5 mg/kg and 20 mg/kg cocaine significantly increased the time spent in cocaine-paired chamber by both wild type and DAT-KD mice. Statistical analysis with ANOVA indicated a main drug effect (F2,40 = 24.25, p < 0.0001), the lack of a difference between genotypes (F1,40 = 0.1180, p > 0.05) and the lack of a drug-genotype interaction (F2,40 = 0.8827, p > 0.05). Post-hoc Bonferroni analysis showed the increase in time spent in the cocaine-paired chamber was significant at 5 mg/kg and 20 mg/kg cocaine for both wild type (p < 0.05 and 0.01 respectively) and DAT-KD mice (p < 0.001 and 0.001 respectively). The time mice spent in the unpaired chamber decreased in the cocaine treated groups (data not shown). Therefore, the rewarding effect of cocaine is preserved in DAT-KD mice in which the activity of DAT, the primary target of cocaine, is dramatically reduced.
###end p 19
###begin p 20
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cocaine induced CPP in DAT-KD mutant mice and WT mice</bold>
###xml 302 306 302 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2,1 </sub>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
Cocaine induced CPP in DAT-KD mutant mice and WT mice. CPP is represented by the difference in the time mice spend in the drug-paired chamber between pre-conditioning day and post-conditioning day. Both 5 and 20 mg/kg cocaine produced significant CPP in both WT mice and DAT-KD mice (for drug effect, F2,1 = 24.25, p < 0.0001). Eight mice were examined in each group. Error bars represent standard error of means. Post hoc Bonferroni tests versus saline: *, p < 0.05; **, p < 0.01; ***, p < 0.001.
###end p 20
###begin title 21
Discussion
###end title 21
###begin p 22
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 555 560 <span type="species:ncbi:10090">mouse</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 854 858 <span type="species:ncbi:10090">mice</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
###xml 1197 1201 <span type="species:ncbi:10090">mice</span>
###xml 1347 1351 <span type="species:ncbi:10090">mice</span>
The dopamine transporter is a key component in the regulation of DA neurotransmission. Most evidence suggests that the blockade of DAT and the subsequent increase in extracellular DA primarily mediate the stimulating and rewarding effects of cocaine. However, the persistence of the rewarding effect of cocaine in DAT-KO mice suggests a mechanism of DAT-independent cocaine reward, which might be due to the extensive adaptive changes in DAT-KO mice. To test whether the DAT-independent cocaine reward also plays a role in normal mice, we made a knock-in mouse line with the endogenous DAT replaced by a cocaine-resistant DAT mutant. In these DAT-CI mice, cocaine suppresses locomotion and does not produce reward, supporting the hypothesis that cocaine blockade of DAT is required for cocaine reward in normal mice [17]. However, DAT activity in DAT-CI mice is significantly lower than that in wild type mice, and changes in DAT have been shown to alter behaviors or drug responses. For example, reduced DAT activity in DAT-KD mice has been shown to alter behavioral responses to amphetamine, another psychostimulant that impacts the dopaminergic system [18]. It remains a concern that in DAT-CI mice the lack of cocaine response might be due to compensatory changes from the lowered DAT activity. Therefore, we studied cocaine effects on DAT-KD mice.
###end p 22
###begin p 23
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
The DAT-KO and DAT-CI mice were generated using ES cells from 129Sv/J mice and crossed with C57BL6 mice, thus they have a mixed genetic background [17]. Several studies used mice that were backcrossed with C57BL6 mice for many generations [17]. The original DAT-KD mice were generated in 129Sv/J background but this strain does not respond well in many tests that are used to evaluate psychostimulant effects. Therefore, the DAT-KD mice used in this study were backcrossed to C57BL/6J for 8 to 9 generations and thus their background matches with the backgrounds of both the DAT-CI mice and DAT-KO mice. This is important because it has been shown that cocaine's effects are not the same in different strains of mice [21,22]. In addition, DAT-KO mice backcrossed to different strain backgrounds also respond to cocaine differently [23].
###end p 23
###begin p 24
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 1034 1038 <span type="species:ncbi:10090">mice</span>
###xml 1117 1121 <span type="species:ncbi:10090">mice</span>
In DAT-KD mice, DAT activity is reduced to 10% of the wild type level, resulting in a hyperdopaminergic tone and increased locomotor activity [18]. In addition, DAT-KD mice have an altered response to amphetamine, which might be due to an altered balance between DA autoreceptor and heteroreceptor functions [18]. Amphetamine elevates extracellular DA by interacting with DAT and, more importantly, with the vesicular monoamine transporter, inhibiting DA uptake, and inducing DA release from DA containing vesicles to the cytosol through the vesicular monoamine transporter and to the extracellular space through DAT [5]. In contrast, cocaine elevates extracellular DA by simply binding to DAT and inhibiting DA reuptake. Despite the vastly different mechanisms of action, amphetamine and cocaine both increase DA in the synapse and enhance dopaminergic neurotransmission, thereby stimulating locomotor activity and producing reward in animals. The fact that amphetamine produces locomotor inhibition instead of stimulation in DAT-KD mice suggested the possibility that cocaine effects might also be altered in these mice.
###end p 24
###begin p 25
###xml 5 6 5 6 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 314 315 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 1423 1425 1423 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1622 1624 1622 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 1196 1200 <span type="species:ncbi:10090">mice</span>
###xml 1212 1216 <span type="species:ncbi:10090">mice</span>
###xml 1241 1245 <span type="species:ncbi:10090">mice</span>
###xml 1329 1333 <span type="species:ncbi:10090">mice</span>
###xml 1362 1366 <span type="species:ncbi:10090">mice</span>
###xml 1438 1442 <span type="species:ncbi:10090">mice</span>
###xml 1616 1620 <span type="species:ncbi:10090">mice</span>
###xml 1699 1703 <span type="species:ncbi:10090">mice</span>
###xml 1715 1719 <span type="species:ncbi:10090">mice</span>
###xml 1817 1821 <span type="species:ncbi:10090">mice</span>
###xml 2101 2105 <span type="species:ncbi:10090">mice</span>
###xml 2436 2440 <span type="species:ncbi:10090">mice</span>
###xml 2523 2527 <span type="species:ncbi:10090">mice</span>
###xml 2673 2677 <span type="species:ncbi:10090">mice</span>
Fig. 1 shows that DAT-KD mice had considerably higher baseline locomotor activity than WT mice before drug or saline injection and this difference was statistically significant (Fig. 1C). This result confirms our previous observation [18] and is consistent with the hyperdopaminergic tone in these mice [18]. Fig. 1 also shows that cocaine clearly increased locomotor activity in DAT-KD mice as well as in WT mice. While cocaine was capable of increasing locomotor activity in both genotypes, there were differences in each genotype's response. For instance, both 5 and 10 mg/kg cocaine produced stronger locomotor stimulation in DAT-KD mice than it did in wild type mice (Fig. 1D). The reason for this difference is not clear but could be due to presynaptic or postsynaptic adaptive changes, such as reduced D2 autoreceptor signaling, in response to the hyperdopaminergic tone in DAT-KD mice. It is also not clear why the amphetamine effect is altered in DAT-KD mice while the cocaine effect is maintained. Our results demonstrate that a dramatically reduced DAT activity does not lead to a loss or a reduction of the stimulating effect of cocaine. This is in contrast to observations of DAT-KO mice and DAT-CI mice. In heterozygous DAT-KO mice, DAT activity is reduced by 50% and cocaine stimulates locomotion as well as in WT mice; while in homozygous DAT-KO mice, DAT is absent and cocaine has no effect on locomotion [24]. In DAT-CI mice, the mutated DAT is over 50-fold less sensitive to cocaine inhibition but has lower uptake activity. Instead of stimulation, cocaine suppresses locomotor activity in DAT-CI mice [17]. The fact that cocaine retains these effects in both heterozygous DAT-KO mice and DAT-KD mice indicates that the reduction of DAT expression and thus DAT activity to 50% and 10% of wild type mice does not by itself lead to adaptive changes that abolish the stimulating effect of cocaine and in fact, 10% DAT activity seems to be sufficient for the preservation of many normal functions, such as some cocaine responses. Therefore, the locomotor suppression observed in DAT-CI mice is not due to reduced DA clearance or changes in DA homeostasis but is due to the lack of cocaine inhibition of DAT and to cocaine effects on other cocaine targets. Cocaine inhibition of DAT, SERT, and NET and the resulting enhancement of neurotransmission in all three systems may contribute to the locomotor effect in wild type mice. Cocaine inhibition of SERT and/or NET in the absence of DAT inhibition in DAT-CI mice leads to locomotor suppression. It is not clear whether cocaine inhibition of SERT or NET enhances or dampens locomotor stimulation in wild type mice where DAT is also inhibited. Further studies are being performed to assess the role of SERT and NET in locomotor suppression.
###end p 25
###begin p 26
###xml 65 71 <span type="species:ncbi:9606">humans</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Cocaine and other addictive drugs are known to produce reward in humans as well as in mice and other animals. CPP tests are commonly used to measure the rewarding properties of drugs. In this behavioral test, drug administration to animals is repeatedly paired with a set of environmental cues. When allowed to explore freely, the animals spend more time in the environment paired with a drug that produces reward.
###end p 26
###begin p 27
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 919 920 919 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1048 1049 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
###xml 1042 1046 <span type="species:ncbi:10090">mice</span>
###xml 1194 1198 <span type="species:ncbi:10090">mice</span>
Previously we have shown that up to 20 mg/kg cocaine is not enough to inhibit the cocaine-insensitive mutant DAT and elevate extracellular DA in DAT-CI mice [17]. We have also shown that cocaine lost its ability to produce reward in DAT-CI mice while amphetamine still produces CPP in these mice. Therefore, we conclude that the reward pathway in DAT-CI mice is functional and the lack of cocaine-induced reward in DAT-CI mice is due to the inability of cocaine to block the modified DAT. However, DAT activity in DAT-CI mice is significantly lower than that in WT mice. The DA clearance rate in DAT-CI mice is between those of DAT-KD mice and heterozygous DAT-KO mice [17]. It remains a concern that lowered DAT activity might lead to neuroadaptations that may alter cocaine effects. Thus, we examined whether cocaine is still able to produce reward in DAT-KD mice that have only 10% of wild type DAT expression. Fig. 2 shows that cocaine still produced robust CPP in DAT-KD mice. In addition, cocaine produces reward in heterozygous DAT-KO mice [9-11]. These results demonstrate that the reduction of DAT activity and elevated dopaminergic tone does not abolish cocaine's rewarding effect in mice.
###end p 27
###begin p 28
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
Several mouse models have been generated with alterations to the DAT gene, providing excellent tools to study the functions of DAT and the mechanism of cocaine effects: DAT-KD mice [18] and heterozygous DAT-KO mice [24] with DAT expression reduced to 10% and 50% of the wild type level respectively, DAT-CI mice [17] with a cocaine-insensitive DAT mutant that is functional but with reduced uptake activity, and homozygous DAT-KO mice [24] with DAT completely deleted. Heterozygous DAT-KO mice [24]and DAT-KD mice have significantly elevated DA tone but in these mice DAT is blocked by cocaine and the mice respond to cocaine similarly to wild type mice. The adaptive changes to the elevated dopaminergic tone in these mice are likely to be moderate. The changes do not abolish cocaine's ability to produce reward or to stimulate locomotor activity. Therefore, it is likely that the mechanism of cocaine action in these mice is similar to that in wild type mice.
###end p 28
###begin p 29
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 540 545 <span type="species:ncbi:10090">mouse</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
###xml 820 824 <span type="species:ncbi:10090">mice</span>
In DAT-CI mice, DA uptake activity is reduced and the basal DA tone is also significantly elevated [17]. Since the extent of basal DA elevation in DAT-CI mice is between those in heterozygous DAT-KO and DAT-KD mice [17], it is reasonable to assume that the adaptive changes in DAT-CI mice are also moderate and do not interrupt the drug reward pathway. We have shown that amphetamine still produces reward in DAT-CI mice suggesting a functional reward pathway [17]. Although the elevated basal DA tone is due to reduced DAT activity in all mouse lines, the causes of the reduction are different; reduced expression of wild type DAT, in heterozygous DAT-KO and DAT-KD mice, versus normal expression of a mutant DAT with lower uptake activity in DAT-CI mice. Therefore, it is still possible that the mutated DAT in DAT-CI mice may cause unique adaptive changes, by an unknown mechanism, which could abolish cocaine reward and locomotor stimulation.
###end p 29
###begin p 30
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
In contrast, in homozygous DAT-KO mice DAT is completely lacking. Intriguingly, the elimination of DAT, the consequent severe alteration of DA homeostasis and related pathways, and the tremendous adaptive changes still fail to abolish the rewarding effect of cocaine [24]. However, the mechanism of cocaine reward in DAT-KO mice is very different from that in wild type mice. For example, inhibition of SERT or NET with selective inhibitors elevates DA levels in the nucleus accumbens and produces reward in DAT-KO mice but not in wild type mice [24]. These results indicate that the complete deletion of DAT significantly alters the mechanism of cocaine effects. It seems that cocaine-induced DA elevation in the nucleus accumbens is still critical and the signaling from serotoninergic or noradrenergic systems to the dopaminergic system might be altered. The exact mechanism is not clear and currently under intensive investigation.
###end p 30
###begin title 31
Conclusion
###end title 31
###begin p 32
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
In summary, genetically modified mouse strains with a reduction in DAT function by 50% (heterozygous DAT-KO mice) and 90% (DAT-KD mice) retain the stimulating and rewarding effects of cocaine. These results are consistent with the idea that reduced DAT activity in DAT-CI mice does not lead to adaptive changes that abolish the stimulating and rewarding effects of cocaine. Therefore, the lack of cocaine reward and locomotor stimulation in DAT-CI mice is unlikely due to reduced DAT activity or the resulting hyperdopaminergic tone, but due to the inability of cocaine to inhibit the modified DAT. This investigation lends further support to the conclusion that cocaine inhibition of DAT is necessary for the rewarding and stimulating effects of cocaine.
###end p 32
###begin title 33
Methods
###end title 33
###begin title 34
Animals
###end title 34
###begin p 35
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 910 920 910 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum</italic>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">Mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 778 782 <span type="species:ncbi:10090">Mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
The DAT-KD mice were generated by the insertion of a DNA construct containing the neomycin-resistant gene and other elements into the promoter region of DAT gene in an attempt to control DAT expression [18]. This promoter modification results in a 90% reduction in DAT expression [18]. Mice used in this study were produced from the breeders that have been backcrossed with C57BL/6J mice for 8-9 generations. Heterozygous male and female DAT-KD mice were bred to produce homozygous DAT-KD mice and their WT littermates used in the experiments. The genotypes of the mice used in these experiments were determined by PCR using forward primer TGGGGTCCACATACAAATGATGA and reverse primer ACACGTGGCAGATTCATAGGTA. Only male mice between 10 and 14 weeks of age were used in this study. Mice were group housed, with 3 - 5 mice per cage, on a 12 hour day/night cycle with lights off at 6 pm. Food and water was provided ad libitum. All procedures were conducted in accordance with the animal use committee at The Ohio State University. Experiments were performed between 9:00 am and 5:00 pm. Only drug naive animals were used in experiments and separate animals were used for the locomotor and CPP studies.
###end p 35
###begin title 36
Drugs
###end title 36
###begin p 37
The drug supply program of National Institute on Drug Abuse, NIH (Bethesda, MD), kindly supplied cocaine HCL. Doses of 5 mg/kg, 10 mg/kg and 20 mg/kg were given for the locomotion studies and doses of 5 mg/kg and 20 mg/kg were used for the CPP studies. Vehicle (0.9% NaCl) and cocaine were administered through intraperitoneal (i.p.) injection.
###end p 37
###begin title 38
Locomotion tests
###end title 38
###begin p 39
###xml 161 165 <span type="species:ncbi:10090">Mice</span>
###xml 351 356 <span type="species:ncbi:10090">mouse</span>
Locomotion tests were performed in acrylic test chambers measuring 25 cm(W) x 25 cm(L) x 25 cm(H) that are inside a sound-attenuating behavioral test enclosure. Mice were placed in the chamber without drugs for 60 min. The total distance traveled during this time was used to determine the basal activity. Then cocaine or vehicle was administered and mouse locomotor activities were monitored for another 60 minutes. Cumulative distance traveled and speed was recorded by a video-based monitoring system, Limelight (Actimetrics, Evanston, IL). The stimulatory effects of cocaine peaked between 10 and 20 minutes, thus we used distance traveled within the first 30 minutes after injection as a measurement of cocaine effect on locomotion.
###end p 39
###begin title 40
Conditioned place preference
###end title 40
###begin p 41
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 735 739 <span type="species:ncbi:10090">Mice</span>
###xml 802 806 <span type="species:ncbi:10090">Mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
###xml 1064 1068 <span type="species:ncbi:10090">mice</span>
###xml 1193 1197 <span type="species:ncbi:10090">mice</span>
CPP was performed as previously described [17]. In this setup, we used a three-chambered box with the two end chambers differing in wall patterns and floor materials. One chamber had a thin wavy pattern on a white background on the walls and thin-mesh flooring, while the other chamber had a thick grid pattern on a white background on the walls and thick-mesh flooring. The middle chamber, used as a neutral initial placement point, had gray walls and a slick, acrylic floor. On the pre-conditioning day (day 1) mice were locked in the middle chamber for 30 seconds, then allowed to freely explore the entire apparatus for 30 min. Movement and time spent in each chamber was recorded with the video-based monitoring system LimeLight. Mice did not show a significant preference for either end chamber. Mice were randomly paired to one end chamber and randomly divided into saline control and cocaine-injected groups. On days 2, 4, 6, and 8, the mice were injected with saline and confined in one of the two end chambers for 30 min; and on days 3, 5, 7, and 9, the mice were injected with cocaine or saline and confined to the opposite end chamber for 30 minutes. On the test day (day 10), the mice were confined to the central chamber for 30 seconds, and then allowed free access to both end chambers for 30 min. The time spent in each of the end chambers was recorded. The difference between the time spent in the paired chamber on pre-conditioning day and time spent in the same chamber on post-conditioning day was calculated and presented.
###end p 41
###begin title 42
Data analysis
###end title 42
###begin p 43
The experimental data were analyzed by two-way ANOVA and post hoc Bonferroni tests using GraphPad Prism (GraphPad Software, Inc. San Diego, CA)
###end p 43
###begin title 44
Authors' contributions
###end title 44
###begin p 45
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 265 270 <span type="species:ncbi:10090">mouse</span>
MT carried out the behavioral tests, analyzed data, designed experiments and participated in drafting the manuscript. BC and XZ generated and backcrossed the DAT-KD mice. DH and NT continued the backcrossing of DAT-KD mice, performed genotyping, and maintained the mouse colony. HG conceived of the study, analyzed data, and was responsible for its design and coordination, and for drafting the manuscript. All authors read and approved the final manuscript.
###end p 45
###begin title 46
Acknowledgements
###end title 46
###begin p 47
The authors thank Erik Hill for reading and editing the manuscript. This research was supported by grants from National Institute on Drug Abuse (DA14610 awarded to Howard H. Gu) and from National Institute of Mental Health (MH66216 awarded to Xiaoxi Zhuang).
###end p 47
###begin article-title 48
A psychomotor stimulant theory of addiction
###end article-title 48
###begin article-title 49
###xml 16 22 <span type="species:ncbi:9606">humans</span>
###xml 122 126 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
###end article-title 49
###begin article-title 50
Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys
###end article-title 50
###begin article-title 51
The dopamine hypothesis of the reinforcing properties of cocaine
###end article-title 51
###begin article-title 52
Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens
###end article-title 52
###begin article-title 53
Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes
###end article-title 53
###begin article-title 54
###xml 110 118 <span type="species:ncbi:9606">patients</span>
Allelic association of a dopamine transporter gene polymorphism with antisocial behaviour in heroin-dependent patients
###end article-title 54
###begin article-title 55
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Cocaine self-administration in dopamine-transporter knockout mice [see comments] [published erratum appears in Nat Neurosci 1998 Aug;1(4):330]
###end article-title 55
###begin article-title 56
###xml 122 126 <span type="species:ncbi:10090">mice</span>
Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice
###end article-title 56
###begin article-title 57
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice
###end article-title 57
###begin article-title 58
Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions
###end article-title 58
###begin article-title 59
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Role of serotonin in cocaine effects in mice with reduced dopamine transporter function
###end article-title 59
###begin article-title 60
Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine
###end article-title 60
###begin article-title 61
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene
###end article-title 61
###begin article-title 62
###xml 98 102 <span type="species:ncbi:10090">Mice</span>
Regional Differences in Extracellular Dopamine and Serotonin Assessed by In Vivo Microdialysis in Mice Lacking Dopamine and/or Serotonin Transporters
###end article-title 62
###begin article-title 63
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter
###end article-title 63
###begin article-title 64
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Hyperactivity and impaired response habituation in hyperdopaminergic mice
###end article-title 64
###begin article-title 65
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Hyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards
###end article-title 65
###begin article-title 66
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward
###end article-title 66
###begin article-title 67
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Effects of "binge" pattern cocaine on stereotypy and locomotor activity in C57BL/6J and 129/J mice
###end article-title 67
###begin article-title 68
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Strain differences in basal and cocaine-evoked dopamine dynamics in mouse striatum
###end article-title 68
###begin article-title 69
Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background
###end article-title 69
###begin article-title 70
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
###end article-title 70

